SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-073966
Filing Date
2023-03-17
Accepted
2023-03-17 16:36:32
Documents
4
Effectiveness Date
2023-03-17

Document Format Files

Seq Description Document Type Size
1 S-8 d461186ds8.htm S-8 33336
2 EX-5.1 d461186dex51.htm EX-5.1 4953
3 EX-23.1 d461186dex231.htm EX-23.1 1421
4 EX-FILING FEES d461186dexfilingfees.htm EX-FILING FEES 21374
  Complete submission text file 0001193125-23-073966.txt   62097
Mailing Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080 650-487-6488
Akero Therapeutics, Inc. (Filer) CIK: 0001744659 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270662 | Film No.: 23743209
SIC: 2834 Pharmaceutical Preparations